dsm-firmenich implements cross-guarantee agreement to mitigate structural subordination
dsm-firmenich announces that it has signed a cross-guarantee agreement with DSM BV, Firmenich International SA and DSM-Firmenich AG to mitigate structural subordination within the group.
The agreement allows the group to develop a centralized financing structure, in line with its commitment to maintain a strong investment grade rating, and to develop a peer platform for existing and future senior unsecured notes.
The cross-guarantee agreement includes downstream guarantees provided by the parent company DSM-Firmenich Group to its wholly owned subsidiaries DSM BV and Firmenich International SA, and upstream guarantees provided by these two subsidiaries to the parent company. The guarantees are irrevocable and unconditional and cover existing and future senior unsecured debt instruments of these entities, including the group's existing senior unsecured bonds.
2026-10-16
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
Univar Solutions Signs Distribution Agreement with DSM-Firmenich
-
DSM-Firmenich sells majority of ROBERTET shares
-
DSM Firmenich sells yeast extract business to Lesaffre
-
DSM Firmenich partners with ExoLab Italia to bring plant-derived exosome technology to the skin care market
-
DSM Firmenich partners with startups to develop natural ingredients
-
Dsm-firmenich increases perfumery ingredients production capacity
-
Dsm Firmenich will spin off Animal Nutrition & Health unit
-
Beiersdorf Launches Eucerin Skincare Brand in Japan
-
Symrise Launches “Care & Wellness” Division to Strengthen Beauty–Health Integration
-
The Pill That Could Swallow the Needle: Novo Nordisk Launches Oral Wegovy in U.S. Weight-Loss Revolution
Recommend Reading
-
BASF Raises API and Excipient Prices
-
From Desert Sands to Dining Tables: Arab Food & Beverage Sector Emerges as Investment Powerhouse
-
BASF Builds New Alkyl Polyglucoside Plant in Thailand, Expands Its Business Footprint in Asia
-
AstraZeneca to Invest $2 Billion in New U.S. Biologics Facilities
-
Korea’s Petrochemical Pivot: Industry Embraces Historic Restructuring to Slash Overcapacity
-
January China MIBK Market Shows a Phased Recovery
-
Sodium Metabisulfite Prices Rise This Week (Mar. 16-20)
-
Raw Material Costs Remain High, Melamine Prices Slightly Increase in China
-
Ethylene Glycol Prices Soar by 36.12% in March
-
January ammonium sulfate market trend in China shows a strong increase